Table 3.
Pediatric and adolescent diseases that were postulated to be associated with vitamin D serum concentrations due to their associations in observational studies
| References | Effect of vitamin D supplementation from RCTs | |
|---|---|---|
| Diseases of the upper airway | [10, 14, 37–40, 51] | + and − |
| Asthma bronchiale | [36, 52, 53] | + and − |
| Attention-deficit/hyperactivity disorder | [54–56] | − |
| Type I diabetes mellitus | [10, 14, 32–35] | No RCT performed |
| Type II diabetes mellitus | [10, 14, 44–50] | + and − |
| High blood pressure | [10, 14, 41, 43] | − |
| Cardiac insufficiency | [10, 14] | − |
| Obesity | [10, 11, 14, 57–59] | No RCT performed |
| Multiple sclerosis | [60–63] | + and −* |
RCT randomized controlled trials, + RCT showed a positive effect from vitamin D supplementation on the studied parameter, − RCT showed no effect from vitamin D supplementation on the studied parameter
*Vitamin D had no effect on the frequency of multiple sclerosis relapses but a positive effect on the number of sclera on MRI